Predictive Analytics Using Artificial Intelligence for Early Detection of Cardiovascular Diseases: Opportunities and Clinical Challenges

Abstract

Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, accounting for millions of deaths annually despite substantial advances in medical science and healthcare infrastructure. Traditional diagnostic methods primarily depend on clinical examination, laboratory investigations, electrocardiography, echocardiography, and physician expertise, which may not always identify high-risk patients during the earliest stages of disease development. The emergence of artificial intelligence (AI), particularly predictive analytics based on machine learning and deep learning algorithms, has introduced a transformative paradigm for cardiovascular risk assessment by enabling the analysis of large-scale heterogeneous clinical datasets with remarkable speed and precision. Predictive analytics integrates electronic health records, wearable sensor data, medical imaging, genomic profiles, lifestyle characteristics, and laboratory findings to identify subtle patterns associated with disease onset before symptoms become clinically evident. This paper examines the opportunities and clinical challenges associated with AI-driven predictive analytics for early cardiovascular disease detection, reviews existing literature, proposes an experimental machine learning framework for risk prediction, evaluates algorithmic performance using realistic experimental results, discusses implementation barriers including interpretability, privacy, ethical concerns, and healthcare integration, and highlights future research directions aimed at improving personalised cardiovascular medicine..